News
-
-
-
COMMUNIQUÉ DE PRESSE
Fielmann Group accelerates international sales growth in Q2/2026 and increases pace of global expansion
Fielmann Group accelerates international sales growth in Q2/2026, with +6% growth driven by expansion strategies and AI technology. Preliminary HY1/2026 financials show €1.25bn in sales. Growth and increased staff capacity expected for HY2/2026 -
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Pentixapharm Holding AG: Pentixapharm Receives FDA Fast Track Designation for [⁶⁸Ga]Ga-PentixaFor for the Subtyping of Primary Aldosteronism
Pentixapharm Holding AG receives FDA Fast Track designation for [⁶⁸Ga]Ga-PentixaFor for subtyping of Primary Aldosteronism, allowing more efficient regulatory review process